118 related articles for article (PubMed ID: 3698510)
21. Inhibitory effect of [Asu1,7]-eel calcitonin on growth hormone-secretion in conscious, freely moving, male rats.
Minamitani N; Chihara K; Kaji H; Kodama H; Fujita T
Endocrinology; 1985 Jul; 117(1):347-53. PubMed ID: 4040012
[TBL] [Abstract][Full Text] [Related]
22. Effect of [Asu1,7]eel calcitonin on prolactin release in normal subjects and patients with prolactinoma.
Kaji H; Chihara K; Minamitani N; Kodama H; Kita T; Fujita T
Acta Endocrinol (Copenh); 1985 Mar; 108(3):297-304. PubMed ID: 3920850
[TBL] [Abstract][Full Text] [Related]
23. Effect of (Asu1,7)E-CT, synthetic analogue of eel-calcitonin, on nociceptive transmission.
Clementi G; Amico-Roxas M; Caruso A; Fiore CE; Trombadore S; Scapagnini U
Pharmacol Res Commun; 1985 Oct; 17(10):967-73. PubMed ID: 2999838
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin.
Clementi G; Prato A; Rapisarda E; Conforto G; Mangano O; Caruso A; Scapagnini U
J Endocrinol Invest; 1985 Dec; 8(6):543-6. PubMed ID: 3833898
[TBL] [Abstract][Full Text] [Related]
25. Enhanced rectal absorption of [Asu1,7]-eel calcitonin in rats using polyacrylic acid aqueous gel base.
Morimoto K; Akatsuchi H; Aikawa R; Morishita M; Morisaka K
J Pharm Sci; 1984 Oct; 73(10):1366-8. PubMed ID: 6502483
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of human calcitonin using labeled [Asu1, 7]-human calcitonin analogue.
Okada Y; Morimoto S; Onishi T; Tanaka K; Tsuji M; Kumahara Y; Tsushima S; Nakazawa N; Ogawa H; Sakakibara S
Endocrinol Jpn; 1978 Dec; 25(6):617-22. PubMed ID: 751807
[TBL] [Abstract][Full Text] [Related]
27. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effects of rectal administration of unmodified eel calcitonin in humans.
Nuti R; Martini G; Frediani B; Giovani S; Valenti R; Marcocci A; Ciappi A
Drugs Exp Clin Res; 1992; 18(9):395-400. PubMed ID: 1338592
[TBL] [Abstract][Full Text] [Related]
30. PDN-21: possible tumor marker for medullary thyroid carcinoma.
Takami H; Shikata J; Horie H; Sekine K; Ito K
J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
[TBL] [Abstract][Full Text] [Related]
31. Synthetic [Asu1,7] eel calcitonin increases phosphorus content in the hepatic bile of intact and nephrectomized rats.
Yamaguchi M; Katayama K
Endocrinol Jpn; 1982 Aug; 29(4):401-6. PubMed ID: 7151741
[TBL] [Abstract][Full Text] [Related]
32. Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion.
Adachi I; Abe K; Tanaka M; Yamaguchi K; Miyakawa S
Endocrinol Jpn; 1976 Dec; 23(6):517-26. PubMed ID: 191250
[TBL] [Abstract][Full Text] [Related]
33. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma--an effect apparently not mediated by gastrin.
Wells SA; Cooper CW; Ontjes DA
Metabolism; 1975 Nov; 24(11):1215-9. PubMed ID: 1186495
[TBL] [Abstract][Full Text] [Related]
36. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.
Morita R; Fukunaga M; Yamamoto I; Mori T; Torizuka K
Endocrinol Jpn; 1975 Oct; 22(5):419-26. PubMed ID: 1061670
[TBL] [Abstract][Full Text] [Related]
38. Effect of intracerebroventricular administration of rat calcitonin gene-related peptide (CGRP), human calcitonin and [Asu1,7]-eel calcitonin on gastric acid secretion in rats.
Okimura Y; Chihara K; Abe H; Kaji H; Kita T; Kashio Y; Fujita T
Endocrinol Jpn; 1986 Apr; 33(2):273-7. PubMed ID: 3489610
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
40. International Standards for salmon calcitonin, eel calcitonin, and the Asu1-7 analogue of eel calcitonin: calibration by international collaborative study.
Zanelli JM; Gaines-Das RE; Corran PH
Bone Miner; 1990 Oct; 11(1):1-17. PubMed ID: 2268734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
